SEC Form 4 · accession 0001144204-15-043276
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — Vice President, Operations
Period of report
Jul 17, 2015
Accepted (ET)
Jul 20, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2015 | M | 7,395 | $6.36 | A | 49,483 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $6.36 | Jul 17, 2015 | M | 7,395 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 7,395 | 14,793 | D |